Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab-Reference-Cited by-同舟云学术

Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab

Published:2016-03 Issue:3 Volume:118 Page:442-446
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Walraven Iris,van den Heuvel Michel,van Diessen Judi,Schaake Eva,Uyterlinde Wilma,Aerts Joachim,Koppe Frederieke,Codrington Henk,Kunst Peter,Dieleman Edith,van de Vaart Paul,Verheij Marcel,Belderbos Jose

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference27 articles.

1. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer;Harris;Int J Radiat Oncol Biol Phys,2014

2. Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65years of age with stage III non-small cell lung cancer;Ezer;Radiother Oncol,2014

3. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Auperin;J Clin Oncol,2010

4. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117;Bradley;Int J Radiat Oncol Biol Phys,2010

5. High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer;Sura;Cancer J (Sudbury, Mass),2007

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial;Radiotherapy and Oncology;2024-11

2. Patient-reported symptom monitoring: using (big) data to improve supportive care at the macro-, meso-, and micro-levels;Supportive Care in Cancer;2024-02-22

3. Hypofractionation for Lung Tumors (Primary Malignant, Secondary Malignant);Hypofractionated and Stereotactic Radiation Therapy;2024

4. Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non–Small-Cell Lung Cancer;Clinical Lung Cancer;2023-11

5. Perspectives thérapeutiques dans la prise en charge des CBNPC de stade III non résécables;Revue des Maladies Respiratoires Actualités;2023-10